关于挚信资本<\/b><\/p> \n
挚信资本是一家中国领先的成长型股权基金管理公司，专注于优质且具有良好增长潜力的投资机会。我们成立于2006年，现资产管理规模约80亿美元，其管理资金主要来自全球领先的大学捐赠基金、退休基金、主权基金及产业战略伙伴。我们依托对人口、技术和行业结构转型等长期基本面的深厚见地，采取生态体系驱动的投资理念，深耕于互联网、内容、教育和医疗领域。我们相信挚信在这些领域所积累的丰富的行业见解和资源能助力我们更好地挖掘并把握独特的投资机会。<\/p> \n
Trustbridge Partners is a leading growth equity fund that focuses on investing in high-quality growth opportunities in China<\/span>. Founded in 2006, Trustbridge currently manages approximately $8 billion<\/span> in assets from leading university endowments, pension funds, sovereign wealth funds, and strategic industry partners. Our investment philosophy is built upon a fundamental understanding of long-term trends in demographics, technology and structural changes. We adopt a unique ecosystem-driven approach and concentrate in the internet, content, education, and healthcare sectors where we believe our deep insights and strong industry relationships help generate unique investing opportunity sets.<\/p> \n 关于<\/b>General Oriental<\/b><\/p> \n General Oriental is a family investment office that exclusively manages the estate of Sir James Goldsmith<\/span> for the economic benefit of his descendants. Sir James Goldsmith<\/span> (1933-1997) was an English industrialist who made numerous investments in Europe<\/span>, North America<\/span> and Asia<\/span> from the 1950s to 1990s, including Bovril, British-American Tobacco, Newmont Mining, Zee TV, INCO Indonesia and Noble Group. Additional information on Sir James Goldsmith<\/span> can be obtained from the websites of http:\/\/www.sirjamesgoldsmith.com<\/a> and http:\/\/en.wikipedia.org\/wiki\/James_Goldsmith<\/a>. General Oriental manages a multi-billion dollar global investment portfolio across all asset classes, including private equity investments in various countries across the Asia Pacific<\/span> region including China<\/span>, Hong Kong<\/span>, Japan<\/span>, Singapore<\/span>, Thailand<\/span> and Indonesia<\/span>.<\/p> \n 关于金浦健康基金<\/b><\/p> \n 金浦健康基金成立于2015年4月，是金浦投资旗下专注于医疗健康行业股权投资的专业型基金。基金聚焦于生物技术与制药、医疗器械、医疗服务等大健康细分领域的投资，成立至今投资项目20余个，被投公司均处于行业领先地位。金浦健康基金践行“分享”与“成长”的企业文化，致力于成为“价值发现者”和“价值创造者”。基金合伙人拥有股权投资和医疗健康领域十五年以上工作经历，团队管理的连续两支基金都获得了全国社保基金和国家开发银行的投资，同时也是第一支获得全国社保基金投资的管理团队，开创了中国养老金投资PE基金的先河。<\/p> \n GP Healthcare Capital is a subsidiary fund of GP Capital, focusing on private equity investment in the healthcare industry. We are interested in a variety of healthcare sub-sectors, including biotechnology, pharmaceuticals, medical devices, medical services, etc. Founded in April 2015<\/span>, GP Healthcare Capital has created and maintained an extensive portfolio of more than 20 leading companies in the related fields. We practice a corporate culture of “Share and Thrive Together” and are committed to becoming a “value discoverer” and a “value creator”. The founding partners have more than 15 years of experience in equity investment and healthcare industry. Two previous funds managed by our management team were both financed by National Social Security Fund (NSSF) and National Development Bank (NDB), and they are the pioneers to receive investments from NSSF in China<\/span>.<\/p>"];
$("#dvExtra").html(content_array[0]);})();